| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |